11th Jan 2021 11:46
SourceBio International PLC - Nottingham-based laboratory services provider - Enters into supply deal with "leading" UK high street retailer and pharmacy group to provide laboratory testing services as part of Covid-19 test rollout. Under 12-month deal, SourceBio will offer PCR testing services from facility in Nottingham. "The service is being trialled initially across a limited number of clinically approved high street sites with the goal to offer larger-scale Covid-19 diagnostic testing across many more UK stores should it prove successful," company says. New deal adds to SourceBio's list of clients which already includes the UK's NHS as well as private healthcare customers.
Current stock price: 226.18 pence
Year-to-date change: up 32% since its AIM float in October
By Eric Cunha; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
SBI.L